Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00085254 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

112

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

DRUG: cilengitide
DRUG: temozolomide
RADIATION: radiation therapy
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)